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ABSTRACT
Mice deficient in the runt homology domain transcription
factor Runx1/AML1 fail to generate functional clonogenic
hematopoietic cells and die in utero by embryonic day
12.5. We previously generated Runx1 reversible knockout
mice, in which the Runx1 locus can be restored by Cre-
mediated recombination. We show here that selective res-
toration of the Runx1 locus in the Tie2 cell compartment
rescues clonogenic hematopoietic progenitors in early
Runx1-null embryos and rescues lymphoid and myeloid
lineages during fetal development. Furthermore, fetal liver
cells isolated from reactivated Runx1 embryos are capable
of long-term multilineage lymphomyeloid reconstitution of
adult irradiated recipients, demonstrating the rescue of
definitive hematopoietic stem cells. However, this rescue of
the definitive hematopoietic hierarchy is not sufficient to
rescue the viability of animals beyond birth, pointing to
an essential role for Runx1 in other vital developmental
processes. STEM CELLS 2009;27:1616–1624
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Runx1/AML1 belongs to a family of transcription factors
playing important roles in various developmental processes.
Runx1 is one of the most frequent targets for leukemic trans-
locations [1–4] and plays an essential role in development of
hematopoietic clonogenic activity in the mammalian embryo
[5–7]. Genetic ablation of Runx1 affects early yolk sac eryth-
ropoiesis [8] and exerts severe effects on fetal liver hemato-
poiesis, resulting in anemia and embryonic lethality by em-
bryonic day (E) 11.5–12.5 [5–7]. Runx1 knockout (KO)
embryos contain no clonogenic hematopoietic progenitors,
and Runx1/ embryonic stem cells cannot contribute to adult
hematopoiesis. Induced ablation of Runx1 in the adult hema-
topoietic system suppresses megakaryocytopoiesis and per-
turbs T- and B-cell differentiation, but does not deplete hema-
topoietic stem cells (HSCs) [9]. Runx1 deficiency in adult
bone marrow results in abnormal myeloproliferation and a
predisposition to lymphoma development [10–12].
During embryonic development several tissues are sequen-
tially involved in hematopoietic activity. Soon after gastrula-
tion, embryonic erythroid and myeloid progenitors emerge in
the yolk sac (YS) [13]. The adult hematopoietic hierarchy
evolves gradually from definitive HSCs localized to the aorta-
gonad-mesonephros (AGM) region, umbilical cord, placenta,
and YS by E10.5–E11.5 [14–20].
Here, using reversible knockout Runx1 mice [21], we show
that selective restoration of Runx1 activity in the embryonic
Tie2 compartment is sufficient to rescue the full spectrum of
committed colony-forming progenitors (CFU-C) in the YS, as
well as long-term repopulating HSCs. Once the integrity of the
Runx1 locus is restored, normal expression of the endogenous
Runx1 proteins is maintained and requires no further external
induction [21]. Rescue of the definitive hematopoietic system
prolongs the life of animals but only until birth, indicating the
involvement of Runx1 in other vitally important developmental
processes. Here we report that Runx1 plays a critical role in
the Tie2þ embryonic compartment and/or its downstream
derivatives for the development of definitive HSCs.
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MATERIALS AND METHODS
Animals
Mice were housed and bred in animal facilities at the University
of Edinburgh. Animals were kept in compliance with Home
Office regulations. All transgenic mice used in these experiments
were backcrossed for a minimum of 6-7 generations to the
C57Bl6 background. Reactivatable Runx1 KO and silent green
fluorescent protein (GFP) reporter mice have previously been
described [21, 22]. Tie2-Cre deletor mice were kindly provided
by M. Yanagisawa [23]. To obtain [Tie2-Cre: Runx1LacZ/LacZ] tri-
ple-transgenic animals [Tie2-Cre: Runx1LacZ/wt] males were
crossed with Runx1LacZ/wt females. The day of discovery of the
vaginal plug was designated as day 0.5.
Southern Blot Analysis
To assess the efficiency of recombination and identify embryos
of interest, Southern blot analysis was performed using both pe-
ripheral blood and tail samples. Genomic DNA was isolated from
blood and tails of the embryos, digested with the NheI enzyme,
and hybridized with the A-probe as described previously [21].
For detection of the Tie2-Cre transgene, a Cre DNA probe was
used.
Analysis of LacZ Expression and
Immunohistochemistry
The X-gal staining in embryos was performed as previously
described [24]. Tie2 and Cre recombinase proteins were recog-
nized using a polyclonal anti-Tie2 antibody and a monoclonal
anti-Cre antibody. Tie2 was revealed with a goat anti-rabbit anti-
body coupled to horseradish peroxidase (HRP) followed by a tyr-
amide signal amplification (TSA; PerkinElmer Life and Analyti-
cal Sciences, Boston, http://www.perkinelmer.com) using cyanin
3 as a fluorescent probe. Cre was revealed with a goat anti-mouse
IgG1 coupled to biotin followed by a streptavidin-HRP, a TSA
amplication using cyanin 2 as a fluorescent probe. When needed,
sections were counterstained with 40,6-diamidino-2-phenylindole.
Fluorescent sections were photographed with a Nikon Eclipse
E800 microscope equipped with the structured Light imaging sys-
tem Optigrid (Optem, Calgary, AB, Canada, http://www.optem.
com). Images were acquired and merged with the Image Pro
Plus software (Media Cybernetics, Crofton, MD, http://www.
mediacy.com).
Clonogenic Methylcellulose Assay
Cells from embryonic tissues were obtained after enzymatic
digestion with collagenase-dispase as described previously [20]
and cultured in the methylcellulose medium (M3434; Stem Cell
Technologies, Vancouver, BC, Canada, http://www.stemcell.com)
according to the manufacturer’s instructions. Hematopoietic colo-
nies were scored after 8 days of culture in duplicates.
Reconstruction of the Runx1 locus in methylcellulose colo-
nies was analyzed by polymerase chain reaction (PCR) using two
sets of primers in two separate reactions for each individual col-
ony: reaction a, for detections of Runx1wt and Runx1Re; reaction
b, for detection of Runx1lacZ. Individual colonies were picked
from the methylcellulose, washed in phosphate-buffered saline,
boiled, and subjected to PCR reactions. The primers used were as
follows: for reaction a, 50-GGCTTCTAGGCTTTGGATGTT-30
and 50-TTCCCACAGCTGAGGACTCT-30 (gives 455-bp product
for wild type and 515-bp product for reactivated Runx1 allele);
for reaction b, 50-GGTTTCCATATGGGGATTGG-30 and 50-
TTCCCACAGCTGAGGACTCT-30 (gives 1000-bp product for
the targeted Runx1/LacZ allele).
Long-Term Repopulation Assay
To detect definitive HSCs, fetal livers were isolated from E13.5
embryos and individually transplanted into irradiated Ly5.1/1
adult recipients ( 6 weeks of age) as described previously [20].
Donor cell contribution into the recipient blood was assessed after
6 weeks and/or longer using flow cytometry analysis upon stain-
ing with anti-Ly5.1 and -Ly5.2 monoclonal antibodies conjugated
with phycoerythrin and fluorescein isothiocyanate, respectively
(eBioscience, San Diego, http://www.ebioscience.com). Donor-
derived lymphoid and myeloid fractions were assessed by flow
cytometry in the recipient peripheral blood, bone marrow, spleen,
and thymus as described previously [25]. To this end, monoclonal
CD3e (PE conjugated), CD220 (biotinylated, detection by strepta-
vidin-APC); CD8a (PE conjugated), CD4a (biotinylated, detection
by streptavidin-APC), CD11b (PE conjugated), and GR1 (biotin-
ylated, detection by streptavidin-APC) antibodies were used (BD
Biosciences, San Diego, http://www.bdbiosciences.com). Appro-
priate isotype controls were used. Dead cells were excluded using
7-amino-actinomycin D.
RESULTS
Experimental Design
Reversible Runx1 knockout mice have been described previ-
ously [21]. Briefly, the Runx1 locus in these mice is disrupted
by a stop cassette containing LacZ reporter flanked by LoxP
sites. Runx1LacZ/LacZ phenotype is embryonic lethal by E12.5.
If Cre-recombinase is expressed in the Runx1LacZ/LacZ fertil-
ized eggs, the Runx1 locus is restored and becomes fully
functional; these mice survive and develop normally. Apart
from hematopoietic cells, Runx1 is expressed in some endo-
thelial and mesenchymal cells, motoneurons, cartilage, bone,
and some other cell types [26–29]. Crossing lineage-specific
Cre deletor mice with reversible knockout Runx1 mice ena-
bles lineage-specific rescue of Runx1 expression. Here we
used Tie2-Cre deletor mice to test if rescue of the Runx1
locus in the Tie2 expressing cell compartment is sufficient to
Figure 1. Experimental design. Crossing of [Tie2-Cre: Runx1LacZ/
wt] males with Runx1LacZ/wt females produced embryos of six differ-
ent genotypes of which 1 of 8 is [Tie2-Cre: Runx1LacZ/LacZ]. E12.5
yolk sacs were tested in a methylcellulose assay for the presence of
hematopoietic colony-forming cells. E13.5 fetal livers from individual
embryos were assayed for the presence of definitive hematopoietic
stem cells using a long-term repopulating assay and subsequently by
transplantation into secondary recipients. Abbreviations: E, embryonic
day; MC, methylcellulose.
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rescue HSCs. Tie2 receptor tyrosine kinase marks vascular
endothelium [30] and some hematopoietic cells, including
HSCs [31, 32]. By a two-step breeding, litters were produced
that contained compound transgenic [Tie2-Cre: Runx1LacZ/
LacZ] embryos (about 1/8 of all littermates). The rescue of
clonogenic hematopoietic progenitors was tested by an in
vitro methylcellulose assay and rescue of definitive HSCs was
tested by an in vivo long-term repopulation assay (Fig. 1).
Cre-Mediated Recombination in [Tie2-Cre: sGFP]
Embryos
To assess the reactivation pattern of Runx1 in [Tie2-Cre: Run-
x1LacZ/LacZ] embryos, control crossing of Tie2-Cre males with
silent reporter sGFP females [22] was set up. Tie2-Cre mice
have been previously characterized [23] and used in a number
of publications [33–41]. As expected, GFP expression in trans-
genic [Tie2-Cre: sGFP] embryos highlighted the developing
vasculature (Fig. 2A–2C). The endothelial lining of the dorsal
aorta coexpressed Tie2 and Cre-recombinase (Fig. 2D–2G).
Some double-positive circulating cells were also observed (not
shown). On rare occasions we observed single positive cells,
which could be a reflection of differing rates of maturation and/
or stability of Cre and Tie2 proteins (not shown).
Tie2 was coexpressed with Flk1 and VE-cadherin, tradi-
tionally used as endothelial markers, as indicated by the dy-
namics of development of the Flk1þTie2þ and VE-cadþTie2þ
populations during E8.5–E10.5 (supporting information Fig.
Figure 2. Cre-mediated recombination in
[Tie2-Cre: sGFP] embryos. (A): Activation
of green fluorescent protein in the vascula-
ture network of the E9.5 embryo. (B, C):
Magnified images of intersomitic vascular
network and yolk sac vascular network.
(D–F): Transverse sections of E10.5
embryo through the aorta-gonad-mesoneph-
ros region. (D): Anti-Tie2 antibody staining
(green); (E) anti-Cre-recombinase antibody
staining (red); (F) merged (D) and (E) and
40,6-diamidino-2-phenylindole staining
(blue, not shown) images. Note lateral
(arrowhead) and ventral (arrow) intra-aortic
clusters. (G): Magnified image of the lat-
eral intra-aortic cluster shown in (F) by
arrowhead. Abbreviations: Ao: dorsal aorta;
CV: cardinal veins; Ms: mesenterium.
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Figure 3. Recombination in E11.5 [Tie2-
Cre: Runx1LacZ/LacZ] embryos. (A, C, D,
E): Heterozygous Runx1LacZ/wt embryo; (B,
C0, D0, E0) [Tie2-Cre: Runx1LacZ/LacZ]
embryo; (A, B) general view (arrows: um-
bilical cords; arrowheads: placentas); (C,
C0) head; (D, D0) yolk sac; (E, E0) cord.
LacZ expression marks a number of nonhe-
matopoietic sites (such as motoneurons,
somites, limbs) in all embryos. Note that
the LacZ expression in hematopoietic sites
of [Tie2-Cre: Runx1LacZ/LacZ] embryos is
either fully absent (placenta) or significantly
attenuated (umbilical cord). Clusters inside
the cord of the Runx1LacZ/wt embryo (E,
arrowhead) are readily observed; compare
with weak LacZ staining in [Tie2-Cre: Run-
x1LacZ/LacZ] embryos (E0, arrowhead). (This
observation is supported by histological
analysis shown in Fig. 4.) Note that LacZþ-
stained hematopoietic cells, typical for het-
erozygous Runx1LacZ/wt embryos, are not
seen in the head or the yolk sac of the
[Tie2-Cre: Runx1LacZ/LacZ] embryo (com-
pare D with D0 and C with C0, respec-
tively). Note slight hemorrhage in the head
of the [Tie2-Cre: Runx1LacZ/LacZ] embryo.
Figure 4. Rescue of intravascular hema-
topoietic cell clusters in the umbilical cord
of E11.5 [Tie2-Cre: Runx1LacZ/LacZ]
embryos. (A, A0): Runx1LacZ/wt embryos:
typical cell clusters adjacent to the endo-
thelial lining of the umbilical artery contain
Runx1/LacZ-positive cells (A, arrowhead).
Note that some endothelial cells underlying
these clusters are LacZþ (A0, arrow). In
addition, many cells in the surrounding
mesenchyme are LacZþ. (B, B0): [Tie2-
Cre: Runx1LacZ/LacZ] embryos: rescue of
intravascular cell clusters due to reconstitu-
tion of targeted Runx1 alleles as a result of
Cre-mediated recombination. Hematopoi-
etic cluster (arrowhead) is LacZ-negative
due to loss of the LacZ stop cassette. Endo-
thelial cells underlying the cluster are also
LacZ-negative, whereas surrounding mes-
enchyme remains LacZþ in line with weak
staining shown in Fig. 3E0.
1A). However, the Tie2þ population also included Flk1- and
VE-cadherin-negative subsets. Thus, Tie2 labels both meso-
derm and the endothelial compartment, both implicated in de-
velopment of primitive and adult-type hematopoietic cells
[42–47]. This explains why GFP labeling occurs in all three
hematopoietic cell populations (Ter119, CD45, and CD41) de-
spite the fact that only the CD41þ population expresses Tie2
in the early embryo (supporting information Fig. 1B). The
CD45 fraction becomes GFPþ with delay compared with the
CD41þ and Ter119þ fractions. This is in line with the mater-
nal origin of the earliest CD45þ population [48] and the
notion that embryo-derived CD45þ population develops later
from embryonic CD41þ progenitors [49, 50]. Embryonic de-
finitive HSCs are also Tie2þ [30–32], which results in com-
plete labeling of the hematopoietic system in the adult (sup-
porting information Fig. 1C).
Selective Reactivation of Runx1 in the Tie2 Com-
partment of [Tie2-Cre: Runx1LacZ/LacZ] Embryos:
Phenotypic Analysis
As described previously, LacZ expression is observed in vari-
ous tissues of Runx1LacZ/wt heterozygous embryos, such as
motoneurons, limbs, olfactory placodes, somitic regions, and
branchial arches (Fig. 3A). The AGM region, YS, umbilical
cord, and placenta are implicated in the development of defin-
itive HSCs and contain Runx1-expressing cells. Intra-aortic
cell clusters are associated with the development of clono-
genic progenitors and definitive HSCs [7, 51–53]. Similar
clusters can be readily observed on whole mount preparations
of, and sections through, the umbilical cord (Figs. 3E and 4A,
4A0). Inside the umbilical cord, large clusters are often local-
ized to the anterior domain of the umbilical cord artery, topo-
graphically corresponding to the ventral domain of the dorsal
aorta (Fig. 3E). Knockout Runx1LacZ/LacZ embryos do not
form intra-aortic clusters, although the embryonic vasculature
contains yolk sac-derived erythroid cells (supporting informa-
tion Fig. 2 and [5]). In [Tie2-Cre: Runx1LacZ/LacZ] embryos,
motoneurons and olfactory placodes remain LacZþ, indicating
that Cre-mediated recombination does not extend to tissues
unrelated to the Tie2 lineage (Fig. 3B). In contrast to Run-
x1LacZ/LacZ embryos, [Tie2-Cre: Runx1LacZ/LacZ] embryos con-
tained rescued clusters that were LacZ-negative due to exci-
sion of the LacZ reporter (Figs. 3E, 3E0 and 4B, 4B0).
Although rescued clusters were observed in umbilical cord
vessels, it was difficult to detect them with certainty in the
dorsal aorta, presumably due to their small size. One explana-
tion for this could be that the subendothelial mesenchyme
within the AGM was not rescued.
Reconstitution of Hematopoiesis in [Tie2-Cre: Run-
x1LacZ/LacZ] Embryos: Functional Analysis
Genotypes of individual embryos were determined by Southern
blot using DNA prepared from tails and peripheral blood (sup-
porting information online Fig. 3). [Tie2-Cre: Runx1LacZ/LacZ]
embryos showed almost entire recombination in blood, and had
very little recombination in tail specimens (5%), consistent
with minor endothelial/hematopoietic-specific recombination
caused by the Tie2-Cre. In contrast to Runx1LacZ/LacZ embryos,
which die by E12.5 of severe hematopoietic deficiency, [Tie2-
Cre: Runx1LacZ/LacZ] embryos survive, but only until birth.
E16.5–E18.5 litters cumulatively contained 11.6% of rescued
[Tie2-Cre: Runx1LacZ/LacZ] embryos (supporting information
Table 1). Extensive hemorrhaging was observed in the neural
system of Runx1LacZ/LacZ embryos by E11.5–E12.5, which may
also be a contributing factor to the early lethality [5, 6, 21].
This is either abolished or significantly attenuated in [Tie2-Cre:
Runx1LacZ/LacZ] embryos (Fig. 3C0). The number of CFU-C and
morphological types of hematopoietic colonies formed by
E12.5 yolk sacs of [Tie2-Cre: Runx1LacZ/LacZ] embryos was
similar to those in Runx1LacZ/wt embryos (Fig. 5A). The restora-
tion of the Runx1 locus in hematopoietic colonies was con-
firmed by PCR analysis (Fig. 5B).
By E18.5, the cellularity of the fetal liver in [Tie2-Cre:
Runx1LacZ/LacZ] embryos was decreased on average by 25%
(Fig. 6A). The average cellularity of fetal spleens was only
0.5  106 compared with 1.4  106 in wild-type embryos,
which is approximately 30% of the wild-type spleen size. The
cellularity of E18.5 thymi was similar to their wild-type coun-
terparts (Fig. 6A), and all major myeloid and lymphoid cell
populations in the peripheral blood were present in propor-
tions similar to those found in wild-type embryos (Fig. 6B–
6E). The decreased cellularity found in the fetal liver and
Figure 5. Rescue of hematopoiesis in [Tie2-Cre: Runx1LacZ/LacZ]
embryos. (A): The number of clonogenic myeloid progenitors in E12.5
yolk sac was assessed in comparison with Runx1LacZ/wt embryos using
a standard methylcellulose assay. Three embryos of each genotype
were used. (Total number of colonies per one yolk sac are show-
n.)([Tie2-Cre: Runx1LacZ/LacZ] embryo is designated Re/Re.) (B): Res-
toration of the Runx1 locus was analyzed in individual methylcellulose
colonies by polymerase chain reaction using two separate reactions (a
and b) with two sets of primers (see ‘‘Materials and Methods’’). Four
representative colonies are shown. Abbreviations: BFU-E, blast-form-
ing unit-erythroid; GEMM, granulocyte, erythrocyte, monocyte, macro-
phage; GM, granulocyte-macrophage; Mac, macrophage; Mast, mast
cell.
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spleen of E18.5 [Tie2-Cre: Runx1LacZ/LacZ] embryos may be a
result of the Runx1 deficiency of stromal components that are
not rescued in these tissues.
Interestingly, thymic cellularity in heterozygous Runx1LacZ/
wt embryos was significantly reduced and contained enhanced
numbers of CD4 single-positive (SP) and decreased number of
CD8 SP thymocytes (Fig. 6E). A previous publication reported
normal size of thymi and partial suppression of both SP popula-
tions concurrent with reduced CD4 SP and enhanced CD8 SP
populations in the periphery of Runx1þ/ adult animals [54].
Definitive HSCs Are Rescued in the [Tie2-Cre: Run-
x1LacZ/LacZ] Embryo
To determine whether the development of HSCs was rescued
in [Tie2-Cre: Runx1LacZ/LacZ] embryos, fetal livers were
Figure 6. Hematopoietic characteris-
tics of E18.5 [Tie2-Cre: Runx1LacZ/
LacZ] embryos. (A): Cellularity of
spleen, liver, and thymus. In [Tie2-Cre:
Runx1LacZ/LacZ] embryos, we observed
a slight but statistically significant
reduction in liver cellularity; the spleen
cellularity is reduced by 2/3; thymus
cellularity is similar to wild-type
embryos. (B, C): Lymphoid and mye-
loid populations in the peripheral blood.
(D, E): Lymphoid populations in the
thymus. Note that whereas [Tie2-Cre:
Runx1LacZ/LacZ] embryos (denoted as
Re/Re) show normal distribution of my-
eloid and lymphoid populations, hetero-
zygous Runx1LacZ/wt embryos show
significant reduction in the number of
B220þ cells in the peripheral blood and
increased ratio between CD4þ and
CD8þ populations in the thymus.
Abbreviations: APC, allophycocyanin;
FITC, fluorescein isothiocyanate; PE,
phycoerythrin; Re/Re, [Tie2-Cre: Run-
x1LacZ/LacZ] embryos; wt/LacZ, Run-
x1LacZ/wt embryos; wt/Re, [Tie2-Cre:
Runx1LacZ/wt] embryos; wt/wt, Runx1wt/
wt embryos. (*p < .05;  p < .01)
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isolated from E13.5 embryos and transplanted into irradiated
mice (Fig. 7A). Livers from [Tie2-Cre: Runx1LacZ/LacZ]
embryos successfully repopulated irradiated adult recipients
for a period of more than 200 days. Further comparison with
recipients of wild-type E13.5 fetal livers showed an unbiased
multilineage contribution of rescued [Tie2-Cre: Runx1LacZ/
LacZ] HSCs into the hematopoietic system (Fig. 7B). Second-
ary transplantations of bone marrow cells from mice reconsti-
tuted with rescued HSCs have also been successful (support-
ing information Fig. 4).
DISCUSSION
The structural organization of the developing hematopoietic
hierarchy is complex. It remains unclear whether the first
Figure 7. Rescue of definitive hematopoietic stem cells in [Tie2-Cre: Runx1LacZ/LacZ] embryos. (A): E13.5 fetal livers were individually trans-
planted into irradiated adult Ly5.1/1 recipients, and their contribution in adult hematopoiesis was assessed using fluorescence-activated cell sort-
ing analysis. Each symbol represents an individual recipient. (B): Primary recipients of wild-type and [Tie2-Cre: Runx1LacZ/LacZ] E13.5 livers
were analyzed for donor (Ly5.2/2) myeloid and lymphoid contribution into peripheral blood and bone marrow. Embryo genotypes are designated
as indicated in legend for Figure 6. Abbreviations: APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; Re/Re, [Tie2-Cre:
Runx1LacZ/LacZ] embryos; wt/LacZ, Runx1LacZ/wt embryos; wt/Re, [Tie2-Cre: Runx1LacZ/wt] embryos; wt/wt, Runx1wt/wt embryos.
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generation of clonogenic myeloid progenitors emerges inde-
pendently of the generation of definitive HSCs that appear
later [55, 56]. Given the hierarchical complexity of the devel-
oping hematopoietic system, it is important to establish in
which cell population the Runx1 transcription factor plays a
critical role in the development of the hematopoietic system.
Here we investigated the effects of selective Runx1 rescue
in the Tie2 embryonic compartment. Previously, selective
genetic ablation of Runx1 in the embryonic Tie2þ cell compart-
ment resulted in hematopoietic deficiency similar to that
observed in E12.5 Runx1 knockout embryos [57]. Due to early
embryonic death and unknown proliferative response of early
embryonic HSCs in a standard methylcellulose assay, it remains
unclear whether development of the first definitive HSCs was
abolished. Here, we functionally tested if Runx1 expression in
the Tie2þ cell compartment is sufficient to rescue clonogenic
hematopoietic progenitors and/or definitive HSCs. To this end,
[Tie2-Cre: Runx1LacZ/LacZ] transgenic embryos were generated
in which Cre-recombinase caused restoration of the Runx1
locus selectively in the Tie2þ cell compartment.
We have found that yolk sac myeloid clonogenic progeni-
tors in E10.5 [Tie2-Cre: Runx1LacZ/LacZ] embryos are fully
rescued, as they are generated in normal numbers and produce
a normal morphological variety of methylcellulose colonies.
The hemorrhage phenotype of Runx1-null embryos almost
fully disappears, suggesting that it is caused by hematopoi-
etic/vascular abnormalities rather than neurological defects.
Normal CFU-C development was rescued in early embryonic
life, and lymphoid and myeloid populations were proportion-
ally represented in the late fetus, although the cellularity of
fetal hematopoietic organs (liver and the spleen) was
decreased. These animals survive until birth (whereas Run-
x1LacZ/LacZ embryos die by E12.5), and we tested whether this
early death is caused by lack of HSCs. E13.5 fetal livers from
rescued animals were transplanted into adult irradiated recipi-
ents. The recipients were successfully engrafted over a 200-
day period, and the pattern of donor-derived myeloid and
lymphoid repopulation was phenotypically indistinguishable
from wild-type transplants.
Runx1 plays an important role in development of selected
neural cell types [25, 58, 59]. As Tie2-Cre-mediated recombi-
nation is selective and does not restore expression of Runx1
in the neural system, neural development failure could be the
main cause of lethality of [Tie2-Cre: Runx1LacZ/LacZ] embryos
at birth [59]. In addition, Runx1 deficiency causes abnormal
development of the sternum that may affect the rigidity of the
rib cage and contribute to the lethal phenotype (A. Liakhovit-
skaia et al., manuscript submitted for publication). Interest-
ingly, previous rescue of the Cbfb (common subunit for
Runx1, 2, and 3 transcription complexes)-null embryos, which
normally die between E12.5 and E13.5, using a Tie2-Cbfb
transgene also resulted in death at birth despite rescue of the
fetal liver hematopoiesis [60].
Tie2 expression in the early embryo labels the endothelial,
mesodermal, and CD41þ populations. Tie2 is also expressed
in developing HSCs [30–32]. However, in Runx1-null
embryos, CD41þ and CD45þ cells are not detectable, either
phenotypically by flow cytometry or functionally. Therefore,
the rescue of the definitive hematopoiesis through reconstitu-
tion of the Runx1 locus occurs either in the hematogenic en-
dothelium [44, 46, 61–64] or in a common progenitor for he-
matopoietic and endothelial cells [43]. Further experiments
are required to establish precise cell targets in which Runx1
deficiency blocks development of HSCs.
CONCLUSION
In conclusion, we have shown here that expression of Runx1
in the embryonic Tie2 compartment (and/or downstream res-
cued progeny) is necessary and sufficient for normal embry-
onic development of both early CFU-C and definitive HSC
populations.
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